These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21450091)

  • 1. Prediction of outcome after diagnosis of metachronous contralateral breast cancer.
    Alkner S; Bendahl PO; Fernö M; Manjer J; Rydén L
    BMC Cancer; 2011 Mar; 11():114. PubMed ID: 21450091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
    Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
    Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of metastasis in women with metachronous contralateral breast cancer.
    Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
    Br J Cancer; 2012 Jul; 107(2):221-3. PubMed ID: 22735901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer.
    Tutzauer J; Sjöström M; Bendahl PO; Rydén L; Fernö M; Leeb-Lundberg LMF; Alkner S
    PLoS One; 2020; 15(4):e0231786. PubMed ID: 32302351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
    Prater J; Valeri F; Korol D; Rohrmann S; Dehler S
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
    Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
    Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.
    Sandberg ME; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K
    Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachronous contralateral breast cancer as first event of relapse.
    de la Rochefordière A; Mouret-Fourme E; Asselain B; Scholl SM; Campana F; Broët P; Fourquet A
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):615-21. PubMed ID: 8948346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contralateral breast cancer: metastasis or second primary cancer?].
    Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B
    Bull Cancer; 1996 Oct; 83(10):870-6. PubMed ID: 8952638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of risk of contralateral breast cancer to the interval since the first primary tumour.
    Rubino C; Arriagada R; Delaloge S; Lê MG
    Br J Cancer; 2010 Jan; 102(1):213-9. PubMed ID: 19920826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer.
    Sandberg ME; Alkner S; Hartman M; Eloranta S; Rydén L; Ploner A; Adami HO; Hall P; Czene K
    Int J Cancer; 2013 May; 132(10):2388-94. PubMed ID: 23034813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing.
    Alkner S; Tang MH; Brueffer C; Dahlgren M; Chen Y; Olsson E; Winter C; Baker S; Ehinger A; Rydén L; Saal LH; Fernö M; Gruvberger-Saal SK
    Breast Cancer Res; 2015 Aug; 17(1):102. PubMed ID: 26242876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study.
    Vichapat V; Garmo H; Holmqvist M; Liljegren G; Wärnberg F; Lambe M; Fornander T; Adolfsson J; Lüchtenborg M; Holmberg L
    J Clin Oncol; 2012 Oct; 30(28):3478-85. PubMed ID: 22927521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for contralateral breast cancer in Chennai (Madras), India.
    Gajalakshmi CK; Shanta V; Hakama M
    Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.
    Vichapat V; Garmo H; Holmberg L; Fentiman IS; Tutt A; Gillett C; Lüchtenborg M
    Breast Cancer Res Treat; 2011 Nov; 130(2):609-18. PubMed ID: 21671018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
    Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
    Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of metachronous contralateral breast cancer in Denmark 1978-2009.
    Rasmussen CB; Kjær SK; Ejlertsen B; Andersson M; Jensen MB; Christensen J; Langballe R; Mellemkjær L
    Int J Epidemiol; 2014 Dec; 43(6):1855-64. PubMed ID: 25326461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral breast cancer: clinical characteristics and impact on prognosis.
    Healey EA; Cook EF; Orav EJ; Schnitt SJ; Connolly JL; Harris JR
    J Clin Oncol; 1993 Aug; 11(8):1545-52. PubMed ID: 8336193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways.
    Vichapat V; Gillett C; Fentiman IS; Tutt A; Holmberg L; Lüchtenborg M
    Eur J Cancer; 2011 Sep; 47(13):1919-27. PubMed ID: 21658939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.